Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

NCT03723824 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped COV-19 pandemic

Conditions

Chronic Hepatitis c
Liver Transplant Infection
Kidney Transplant Infection

Interventions

DRUG: grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®

Sponsor

Taichung Veterans General Hospital

Collaborators

[object Object]